Therapeutic Advances in Thrombosis (Record no. 5053)

MARC details
000 -LEADER
fixed length control field 02629nam a22003017a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240305192334.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220216b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1118410904
International Standard Book Number 9781118410905
040 ## - CATALOGING SOURCE
Transcribing agency Data centre
050 ## - LIBRARY OF CONGRESS CALL NUMBER
Classification number QZ 170
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.1'35–dc23
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name David J. Moliterno
9 (RLIN) 27733
245 ## - TITLE STATEMENT
Title Therapeutic Advances in Thrombosis
250 ## - EDITION STATEMENT
Edition statement 2nd Edition
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. 9600 Garsington Road, Oxford, OX4 2DQ, UK
Name of publisher, distributor, etc. John Wiley & Sons
Date of publication, distribution, etc. 2012
300 ## - PHYSICAL DESCRIPTION
Extent 400 pages
520 ## - SUMMARY, ETC.
Summary, etc. Managing patients with thrombotic vascular disease is complexand challenging:<br/><br/>Ischemic vascular disease remains a complicated interplay ofatherosclerosis and thrombosis—even with the evolution in ourunderstanding of the pathobiology of thrombosis.<br/>There has been tremendous growth in therapeutic options whichare quickly finding their place in daily practice, including aremarkable expansion in the number of intravenous and oralantithrombotic agents and new antiplatelet agents<br/>Now more than ever, all cardiologists, hematologists, andspecialists in vascular medicine, as well as other professionals,such as hospital pharmacists, who deal with prognosis andintervention in preventing thrombosis, need a resource thatdistills current knowledge of this important subject.<br/><br/>Written and edited by today’s leading international,Therapeutic Advances in Thrombosis, 2e providesphysicians with the very latest in medical and surgical advances inantithrombotic therapies. With this comprehensively updated editionyou get:<br/><br/>Coverage of virtually all aspects of venous and arterialthrombotic disease and the corresponding therapies<br/>Strategies to manage specific clinical conditions and how totailor treatment to individual patient needs<br/>Updated chapters covering thrombolysis in ST-elevatedmyocardial infarctions; thrombosis in patients with diabetes,pregnancy, and renal dysfunction<br/>Special emphasis on the pharmacology of novel anticoagulantsand their practical use in venous thromboembolism and atrialfibrillation.<br/>Plus, all chapters fully explore clinical trial designs andoutcomes for particular treatment therapies, as well as contain therelevant ACC/AHA/ESC guidelines, so you can confidently apply whatyou learn.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Medical / General
9 (RLIN) 26821
General subdivision Medical / Cardiology
9 (RLIN) 26817
General subdivision Medical › Cardiology
9 (RLIN) 27540
General subdivision Thrombosis–therapy.
9 (RLIN) 31430
General subdivision Antifibrinolytic Agents–therapeutic use.
9 (RLIN) 31431
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 31432
9 (RLIN) 31433
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   02/16/2022   EBS9528 02/16/2022 02/16/2022 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024